GLUE vs NOK · rev $123.7M vs P/E 87, $78.04B cap
Monte Rosa Therapeutics Inc (GLUE) versus Nokia Corp ADR (NOK) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Nokia Corp ADR (NOK) is a communication equipment company listed on NYSE. It is led by Justin Hotard.
Latest reported GLUE revenue for 2025-12-31 was $123.7M. Net income was -$38.6M. GLUE currently screens at market cap $1.56B.
NOK does not have a complete income-statement cache yet.
GLUE currently screens at market cap $1.56B. NOK currently screens at market cap $78.04B and trailing P/E 87.4.
Not investment advice. Open the GLUE and NOK stock pages for the full models.
Not investment advice.